Dr. Maguire is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Avenue
Silver Spring, MD 20993
Education & Training
- Weill Cornell MedicineClass of 2017
Certifications & Licensure
- MD State Medical License 2022 - 2025
- PA State Medical License 2021 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.Michael H Brave, William F Maguire, Chana Weinstock, Hui Zhang, Xin Gao
Clinical Cancer Research. 2024-11-01 - False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer HarboringandMuta...Jaleh Fallah, Jianjin Xu, Hee-Koung Joeng, Chana Weinstock, Brian L Heiss
JCO Precision Oncology. 2024-08-01 - 3 citationsFDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik
Clinical Cancer Research. 2024-05-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: